Novartis presents well-stocked pipeline with Tekturna combos Novartis has given a pipeline update which reveals plans to launch combinination drugs incorporating its antihypertensive Tekturna and a delay to a possible launch of the kidney cancer therapy Afinitor
Sanofi settles US patent dispute with Teva and Barr Sanofi-Aventis says it has agreed to settle patent infringement suits in the USA with Barr Laboratories and Teva Pharmaceutical Industries over generic versions of the allergy drugs Allegra and Nasacort
